Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.
Saved in:
| Title: | Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers. |
|---|---|
| Authors: | King GG; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Baker KK; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Coveler AL; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Harris WP; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Cohen SA; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Shankaran V; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Zhen DB; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Safyan RA; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Lee HH; University of Washington School of Medicine, Seattle, WA 98195, USA., Alidina A; University of Washington School of Medicine, Seattle, WA 98195, USA., Hensel J; University of Washington School of Medicine, Seattle, WA 98195, USA., Hibbert R; University of Washington School of Medicine, Seattle, WA 98195, USA., Durm GA; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA., LaFary YC; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA., Younger A; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA., Kugel S; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Collisson E; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Konnick EQ; University of Washington School of Medicine, Seattle, WA 98195, USA., Redman MW; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Schneider BP; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA., Pritchard CC; University of Washington School of Medicine, Seattle, WA 98195, USA., Shahda S; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA.; Intellia Therapeutics, Cambridge, MA 02139, USA., Chiorean EG; University of Washington School of Medicine, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. |
| Source: | Cancers [Cancers (Basel)] 2025 May 30; Vol. 17 (11). Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers17111830 |
